MoneyWorks4Me

Granules India informs about quarterly statement of investor complaint

11 Jan 2016 Evaluate

Granules India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1854.05
Dr. Reddys Labs. 1197.75
Cipla 1380.00
Lupin 2093.00
Zydus Lifesciences 1158.25
View more..